NewsScience & Technology

Scientists think they’ve found a way to stop allergic reactions before they happen

By February 15, 2018 No Comments

If you are one of the thousands of Americans who suffer from coughing, sneezing, itchy eyes, a runny nose, a scratchy throat, rashes, hives, or asthma attacks due to an allergy, you will be very pleased to find out that help is on the way.

Scientists at Aarhus University in Denmark say they have found a way to use antibodies to stop those nasty allergic reactions from happening.


Want to receive more articles like this in your email inbox every day? Click here to subscribe.
 

The researchers expect that their scientific results will pave the way to developing completely new types of allergy medicine.

The findings, published in Nature Communications, suggest that people who are allergic to birch pollen and insect venom could be treated with a particular antibody that can prevent an allergic reaction from happening altogether.

The new approach for antibody-based treatment of allergy and asthma is regarded as a breakthrough that could have a major impact on development of new medicine in years to come.

According to a statement, the team of researchers from the Departments of Engineering and Molecular Biology and Genetics together with German researchers from Marburg/Giessen were hoping to find new methods to improve existing treatments, but instead they were able to identify how a specific antibody is apparently able to completely deactivate the allergic processes.

The scientist found the antibody follows a complex biochemical process in the human body by which it prevents the human allergy antibody (IgE) from attaching to cells, thus keeping all allergic symptoms from occurring.

That is fantastic news for all people who live with allergies. No more greeting the day with endless sneezing and coughing. No more itching hives.

“We can now describe the interaction of this antibody with its target and the conformational changes very accurately. This allows us to understand, how it interferes with the IgE and its specific receptors on the immune cells of the body, which are responsible for releasing histamine in an allergic reaction,” states Edzard Spillner, associate professor at the Department of Engineering, Aarhus University.

You may be wondering: why do some people have allergic reactions to apparently harmless substances like dust, cat hair or peanuts?

In an allergic reaction the immune system completely overreacts to something that doesn’t trouble most people.

If you are allergic to beestings and you get stung, your immune system overreacts and produces disproportionately huge amounts of a specific type of antibody called immunoglobulin E (IgE)

It is these chemicals that cause those miserable allergy symptoms, including the serious reactions associated with severe food allergies and insect bites.

Common allergy treatments target these immune system compounds or their receptors, thereby minimizing the allergy symptoms.

That’s all good and well, but wouldn’t it be better to completely prevent any allergic reaction from happening?

This magic is what the new approach, namely targeting IgE itself, aims to achieve.

According to the statement, the function of the antibody is that it interferes with binding of IgE to the two specific effector (CD23 and FceRI) on the immune cells, thereby making it impossible for the allergy molecule to bind.

The researchers noticed that the antibody also removes the IgE molecules even after binding to its receptors.

“Once the IgE on immune cells can be eliminated, it doesn’t matter that the body produces millions of allergen-specific IgE molecules. When we can remove the trigger, the allergic reaction and symptoms will not occur,” says Edzard Spillner.

The researchers have conducted ex vivo experiments with blood cells from patients allergic to birch pollen and insect venom. However, the method can be transferred to virtually all other allergies and asthma, says the statement.

The researchers are optimistic that their research results will lead to the development of new types of allergy medicine.


Since you're here...

... we have a small favor to ask. More people are reading Ideapod than ever before, but advertising revenues across the media landscape are falling fast. You see, it takes literally hundreds of hours (and thousands of dollars) per month to create our articles and maintain the spaces online where the community comes together to find inspiration.

If you find any value and inspiration in what we do, we would be so appreciative if you became an Ideapod Prime member of Ideapod. It's $4 per month, with a free 14 day trial. You get to experience Ideapod without advertisements, and will also be invited to a private group where you get direct access to the Ideapod team.

For a limited time, if you sign up for the free 14 day trial you'll get immediate access to our brand new eBook The 7 Most Powerful Articles Published by Ideapod, with an Introduction by Justin Brown, Ideapod Co-Founder.

It takes only 1 minute to join, and you can cancel anytime. You'll be making a huge difference. Thank you.


Coert Engels

Coert Engels

I'm a South African based writer and am passionate about exploring the latest ideas in artificial intelligence, robotics and nanotechnology. I also focus on the human condition, with a particular interest human intuition and creativity. To share some feedback about my articles, email me at coert@ideapod.com.